Interleukin-1 beta enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures

J Clin Endocrinol Metab. 1998 Jul;83(7):2429-34. doi: 10.1210/jcem.83.7.4963.

Abstract

In addition to the well-known modulation of immune and inflammatory responses, the interleukin-1 (IL-1) system has been shown to be involved in the regulation of anterior pituitary hormone secretion and growth. We previously demonstrated that IL-1 receptor antagonist (IL-1ra) is expressed in human pituitary adenomas cultured in vitro. In the present study, we investigated the regulation of IL-1ra protein by IL-1 beta (1-100 U/mL) in human somatotroph adenomas (n = 9) cultured for 12-48 h. IL-1 beta significantly enhanced the concentration of IL-1ra dose dependently in the somatotroph adenoma cell lysates, whereas IL-1ra concentrations remained unchanged in the culture supernatants. Furthermore, basal IL-1ra concentrations were significantly higher in the cell lysates compared with the corresponding culture supernatants. The regulation of IL-1ra in somatotroph adenoma cells is different from human cultured monocytes, in which IL-1 beta significantly stimulated IL-1ra secretion into the culture supernatants, and no change of intracellular IL-1ra content was observed. Incubation of the somatotroph adenoma cells with 100 U/mL IL-1 beta did not result in a change of GH concentrations in the culture supernatants. Enhancement of intracellular IL-1ra protein by IL-1 beta may represent a mechanism intrinsic to somatotroph adenoma cells to counterregulate the response to IL-1 beta on hormone secretion or cellular growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / drug therapy*
  • Adenoma / metabolism
  • Adult
  • Aged
  • Cells, Cultured
  • Female
  • Humans
  • Interleukin-1 / therapeutic use*
  • Male
  • Middle Aged
  • Monocytes / drug effects
  • Monocytes / metabolism
  • Pituitary Neoplasms / drug therapy*
  • Pituitary Neoplasms / metabolism
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Tumor Cells, Cultured

Substances

  • Interleukin-1
  • Receptors, Interleukin-1